点击注册小程序 查看完整报告 特别申明： 本订阅号中所涉及的证券研究信息由光大证券研究所编写，仅面向光大证券专业投资者客户，用作新媒体形势下研究 信息和研究观点的沟通交流。非光大证券专业投资者客户，请勿订阅、接收或使用本订阅号中的任何信息。本订阅号 难以设置访问权限，若给您造成不便，敬请谅解。光大证券研究所不会因关注、收到或阅读本订阅号推送内容而视相 关人员为光大证券的客户。 报告摘要 依托核心技术与国际化布局，构建植保与新材料的综合业务体系 公司是以泰禾集团核心资产整合设立的规范化股份制企业，专注于作物保护及新材料领域发展，并于2025年4 月在深交所创业板上市。历经多年的经营和持续投入，公司逐步形成以百菌清、2,4-D、嘧菌酯、硫代氨基甲 酸酯系列原药为核心的农药产品矩阵，以及四氯丙烯、间苯二甲胺等功能化学品布局。在生产基地方面,公司 以高QHSE标准建成南通如东、徐州新沂、苏州相城、江西新干四大生产基地。随着国际化布局的深入推进， 公司在北美、欧洲、南美等核心农化市场设立境外机构并完成自主登记，同时与先正达、陶氏、安道麦、UPL 等跨国巨头建立了长期稳定的战略合作关系。 全球农药行业景气有望回升，核心产 ...

Group 1 - The company, Sully Co., stated that some of its raw material products will be used in the production of formulated products, such as Bacillus thuringiensis and Pyraclostrobin [2]

"十四五"时期是中国农药工业发展史上极不平凡的五年。五年来，行业突出高质量发展主题，以深化供 给侧结构性改革为主线，在产业结构优化升级、核心技术攻关、重大项目建设、产业链韧性提升、绿色 低碳转型及数字化智能化发展等方面成效显著，为保障国家粮食安全和农产品质量安全奠定了坚实的产 业基础。 产业结构优化升级 "十四五"期间，中国农药工业全力推进总量控制与结构优化，产业布局更加合理，企业入园率显著提 高，集约化、规模化发展水平迈上新台阶，行业整体抗风险能力逐步改善。 2021—2024年国内农药总产量年均复合增长率达8.4%，2024年规上企业数量创历史新高。在企业规模 稳步提升的同时，产业集中度显著提高。2024年销售额超50亿元的企业达13家，超10亿元的企业达81 家，我国有13家企业进入全球农药行业20强。我国农药出口到180多个国家和地区，农药出口成为产业 增长引擎，出口比重超过80%，深度参与全球中间体—原药—制剂的全链条供应链体系，综合实力和国 际竞争力稳步增强。 创新能力稳步增强 智能制造初见成效 在技术装备领域，骨干企业积极推动工艺创新，与高校、装备制造企业紧密合作，实现了重要突破。其 中，万吨级 ...

Group 1 - The core products of the company, including Bacillus thuringiensis, 2,4-D, and pyraclostrobin, are experiencing sustained supply-demand tension in the market [1] - In the third quarter, the price of Bacillus thuringiensis remained at a high level, and the sales volume and profit of products increased due to concentrated shipments and the impact of order delivery schedules [1] - The demand for the company's core products is driven by the promotion of genetically modified crop planting and the significant expansion of planting areas in South America [1] Group 2 - The company's third-quarter report indicates that it achieved an operating income of 1.477 billion yuan, representing a year-on-year increase of 38.89% [1] - The net profit attributable to the parent company for the third quarter was 185 million yuan, reflecting a year-on-year growth of 204.65% [1] - Factors such as rolling order deliveries, channel stocking behaviors, and market psychology of "buying on the rise and not on the fall" have further amplified demand support [1]

Group 1: Performance Drivers - The core products such as Bacillus thuringiensis, 2,4-D, and Pyraclostrobin are experiencing sustained market supply and demand tension, with Bacillus thuringiensis prices at a temporary high in Q3 [2] - The sales volume and profit of these products increased due to concentrated shipments and order delivery schedules in Q3 [2] Group 2: Market Analysis - The demand for core products is boosted by the promotion of genetically modified crops and the significant expansion of planting areas in South America [2] - Consumer psychology of "buying high, not low" and behaviors like rolling order deliveries and channel stocking further support demand [2] Group 3: New Projects and Innovations - The price of Pyraclostrobin has slightly increased and remains stable, with no pressure on current capacity utilization [3] - The company is focusing on new materials and advancing high-contribution business directions, particularly in MX series products and downstream fluorinated materials [3] - The newly created pesticide, Cyhalofop-butyl, has launched under the "Bai Shi Jia" brand and has obtained domestic registration, with overseas registration in progress [3] Group 4: Competitive Advantages and Efficiency - Core products like Bacillus thuringiensis and 2,4-D are classified as restricted products in China, preventing new capacity approvals [3] - The company is enhancing capacity utilization through automation and process optimization, reducing energy consumption and labor costs while minimizing waste emissions [3] Group 5: Talent Development and Incentives - The company is building a "professional and composite" talent team across multiple business sectors and plans to attract high-end talent through long-term incentives [3] - The incentive plan is currently under adjustment, with no specific timeline for implementation [3] Group 6: Risk Considerations - The information shared in this survey does not constitute a substantive commitment to investors regarding external environment judgments, company development strategies, or future plans [3]

Fundraising Adjustment Overview - A total of 33 companies have undergone fundraising adjustments during their IPO processes since 2025, with 5 companies reducing their fundraising amounts [1][29] Company-Specific Adjustments 1. Suzhou New Guangyi Electronics Co., Ltd. - The total fundraising amount was reduced from 800 million to 638 million, a decrease of 162 million, and the number of projects was cut from 2 to 1, focusing on functional materials [3][4] - The adjustment aims to strengthen core business and mitigate competition risks by concentrating resources on traditional advantages in functional materials [4] 2. Nabichuan New Energy Co., Ltd. - The total fundraising amount decreased from 829 million to 729 million, a reduction of 100 million, with the number of projects reduced from 3 to 2 [8][9] - The adjustment reflects a response to regulatory concerns regarding production capacity and aims to focus on core strategic projects while addressing liquidity pressures [9] 3. Yunhan Xincheng (Shanghai) Internet Technology Co., Ltd. - The total fundraising amount was significantly reduced from 942 million to 522 million, a decrease of 420 million, and the number of projects was cut from 4 to 3 [13][14] - The adjustment was made to enhance the rationality of the IPO plan and respond to market skepticism regarding the necessity of the original fundraising for liquidity [14][15] 4. Nantong Taihe Chemical Co., Ltd. - The total fundraising amount was reduced from 1.754 billion to 1.045 billion, a decrease of 709 million, and the number of projects was cut from 5 to 2 [18][19] - The adjustment was driven by regulatory inquiries and the need to improve the rationality of fundraising projects, particularly in light of fluctuating performance [19] 5. Shenzhen Shihang New Energy Co., Ltd. - The first adjustment increased the total fundraising from 1.511 billion to 3.512 billion, a rise of 2.001 billion, while the second adjustment reduced it from 3.512 billion to 1.211 billion, a decrease of 2.301 billion [23][26] - The adjustments reflect strategic expansion needs and responses to regulatory inquiries regarding production capacity and market conditions [24][27] Summary of Trends - Companies are increasingly focusing on core business areas and reducing fundraising amounts in response to regulatory inquiries and market conditions [29][30] - The adjustments indicate a shift towards more prudent financial planning and a strategic focus on competitive advantages in their respective industries [30]

Group 1: Performance Drivers - The core products 2,4-D, pyraclostrobin, and chlorothalonil have been in high demand, with 2,4-D prices increasing since Q2 and chlorothalonil maintaining stable high prices [2] - In Q3, production facilities operated normally without shutdowns, ensuring capacity release, with a slight increase in 2,4-D output compared to the same period last year [2] - Q3 customer orders were robust, with growth in formulation business in Brazil and other regions, focusing on key product shipments [2] Group 2: Competitive Advantages - The supply of restricted directory products like chlorothalonil and 2,4-D is limited, leading to sustained industry prosperity [2] - The engineering complexity of chlorothalonil production (involving key processes like transamination oxidation and chlorination) has led to the exit of major global players, further constraining supply [3] - 2,4-D has achieved breakthroughs in environmental protection, odor control, and quality management in its production process [3] Group 3: Business Developments - Strategic cooperation has been established with Syngenta domestically, and a global cooperation agreement has been signed with UPL, focusing on independent registration, joint development, and exclusive development [3] - The development of new compounds is aimed at supplementing the product structure, particularly in the fungicide sector, to support stable growth in downstream formulation business [3] - The company is focusing on the fluorinated new materials sector as an extension and upgrade of its functional chemicals segment, leveraging existing technological reserves and industry experience [3] Group 4: Incentive Planning - The company is formulating a multi-tiered talent incentive plan to attract industry talent, aligned with global expansion, innovative business, and multi-industry chain development needs; the plan is currently in the adjustment phase with no clear timeline for implementation [3] Group 5: Risk Warning - The information discussed in this research does not constitute a substantive commitment to investors regarding external environment assessments, company development strategies, or future plans; investors are advised to invest rationally and be aware of investment risks [3]

Core Insights - Several A-share companies reported significant profit growth in Q3, with companies like Keli Yuan and Xianda Shares showing over tenfold increases in net profit, driven by factors such as product price increases, expanded sales, business development, and non-recurring gains [1] Group 1: Company Performance - Keli Yuan achieved Q3 revenue of 1.265 billion yuan, a year-on-year increase of 28.31%, with net profit reaching 80.43 million yuan, up 2836.88% [1] - Xianda Shares reported a Q3 net profit of 59.85 million yuan, a staggering increase of 5447.46% [1] - Su Li Co. recorded Q3 revenue of 762 million yuan, a 26.00% increase, and net profit of 59.42 million yuan, up 2750.24% [3] - Huayu Mining's Q3 revenue was 656 million yuan, a 96.97% increase, with net profit of 619 million yuan, up 1315.3% [3] - Jibite announced a Q3 revenue of 1.968 billion yuan, a 129.19% increase, and net profit of 569 million yuan, up 307.7% [3] Group 2: Market Trends and Factors - The significant profit growth for Keli Yuan was attributed to increased revenue and net profit from its nickel battery, consumer battery, and energy storage segments, along with higher investment income from joint ventures [1] - Xianda Shares' growth was driven by a substantial increase in the market price of its main product, as well as new product sales contributing to higher gross margins [1] - Su Li Co. benefited from a recovering agricultural market, with increased sales of its pesticide products and higher prices for its raw materials [3] - Huayu Mining's profit growth was linked to increased product sales and price hikes, along with a revaluation of its acquisition of Asia Pacific Mining [3]

Core Viewpoint - Su Li Co., Ltd. (603585.SH) reported significant growth in revenue and net profit for Q3 2025, driven by a recovery in the agricultural chemical market and increased sales of key products [1] Financial Performance - Q3 revenue reached 762 million yuan, representing a year-on-year increase of 26.00% [1] - Q3 net profit was 59.42 million yuan, showing a remarkable year-on-year growth of 2750.24% [1] - For the first three quarters, revenue totaled 2.064 billion yuan, up 25.39% year-on-year [1] - Net profit for the first three quarters was 139 million yuan, reflecting a year-on-year increase of 1522.38% [1] Market Dynamics - The agricultural chemical market is gradually recovering, contributing to the growth in sales of active ingredients and pesticide formulations [1] - Key products such as Bacillus subtilis, pyraclostrobin, and azoxystrobin saw increased sales volumes and higher unit prices, leading to revenue and gross profit growth [1]

Core Viewpoint - Su Li Co., Ltd. (603585) reported significant growth in its Q3 2025 financial results, driven by a recovery in the agricultural chemical market and increased sales of key products [1] Financial Performance - Q3 revenue reached 762 million yuan, representing a year-on-year increase of 26% [1] - Net profit for Q3 was 59.42 million yuan, showing a remarkable year-on-year growth of 2750.24% [1] - For the first three quarters, net profit totaled 139 million yuan, reflecting a year-on-year increase of 1522.38% [1] Market Factors - The performance improvement is attributed to the gradual recovery of the agricultural chemical market [1] - Increased sales of active ingredients such as Bacillus subtilis, pyraclostrobin, and azoxystrobin contributed to revenue and gross profit growth [1] - The rise in the unit price of Bacillus subtilis also played a significant role in enhancing income [1]